National survey on GERD patients (adults and children) - RGO à trav
Study identifier:NIS-GFR-DUM-2008/2
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
National survey on GERD patients (adults and children)
Medical condition
GERD (gastroesophageal reflux disease)
Phase
-
Healthy volunteers
No
Study drug
-
Sex
All
Actual Enrollment
4400
Study type
Observational
Age
0 Months +
Date
Study Start Date: 01 Jan 2009
Primary Completion Date: -
Study Completion Date: 01 Oct 2009
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Jan 2015 by AstraZeneca Pharmaceuticals
Sponsors
AstraZeneca Pharmaceuticals
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|---|
| 1 For GP : the first 3 consecutive adult patients and the first children seen during the GP’s visit with a diagnosis of GERD. | - |
| 2 For Paediatrics : the first 2 consecutive children seen during the Paediatric's visit with a diagnosis of GERD. | - |
Contacts
Investigators
Principal Investigator
Alain Castaigne
AstraZeneca
